Prevalence of incidental actionable germline mutations in 1,000 advanced cancer patients on a prospective somatic genomic profiling program.
暂无分享,去创建一个
G. Mills | Y. Qi | L. Strong | F. Meric-Bernstam | Hao Zhao | Ken Chen | S. Kopetz | F. Janku | B. Arun | L. Brusco | J. Mendelsohn | M. Routbort | A. Eterovic | K. Shaw | K. Lu | M. Daniels | J. Litton | H. Lara-Guerra | M. Davies